Citi's Global Industrial Tech & Mobility Conference 2026
Logotype for Emerson Electric Co

Emerson Electric (EMR) Citi's Global Industrial Tech & Mobility Conference 2026 summary

Event summary combining transcript, slides, and related documents.

Logotype for Emerson Electric Co

Citi's Global Industrial Tech & Mobility Conference 2026 summary

18 Feb, 2026

Software and AI integration

  • Achieved 9% ACV growth last quarter, targeting 10%+ for the year, driven by integration of AI into core software products and strong customer demand for embedded AI solutions.

  • Three key differentiators: deep domain expertise, mission-critical applications in regulated industries, and a usage-based economic model protect against generic AI threats.

  • Released new AI-powered products like Ovation Virtual Advisor and Aspen Virtual Advisor, with over $100 million in outstanding quotations.

  • Increased R&D investment in software to accelerate innovation and maintain competitive advantage.

  • Customers are actively including the company in their AI roadmaps, seeking support for operational improvements.

Business performance and growth drivers

  • U.S. market is the primary growth engine, supported by strong industrial policy and activity in semiconductors, aerospace, energy, life sciences, and power.

  • Middle East and emerging markets like India and Africa are rapidly growing, offsetting weakness in China and Europe.

  • Power segment saw 74% order growth, with significant opportunities in modernization, data centers, and future greenfield projects.

  • MRO (maintenance, repair, and operations) remains stable, representing about two-thirds of sales and growing at mid-single digits.

  • Test and measurement business achieved 20% order growth and 29% segment EBITDA, with cost synergies realized and ongoing R&D investment in AI tools.

Regional and sector trends

  • U.S. posted 18% growth, with all verticals performing well; Middle East and Asia (outside China) also strong, while Europe and China remain soft.

  • Life sciences seeing U.S. expansions for new drugs, with larger nearshoring investments expected to materialize through 2027–2028.

  • Investments in Saudi Arabia and India are expanding manufacturing capacity to meet demand.

  • Venezuela represents a potential future growth opportunity, with infrastructure and security being monitored.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more